A research group at the University of Helsinki and its partners have found a promising drug candidate for the treatment of amyotrophic lateral sclerosis (ALS). Cerebral dopamine neurotrophic factor CDNF prolongs the lifespan ...
Sep 22, 2023
0
23
For several years, scientists have known that Parkinson's disease is related to misfolding of the protein alpha-synuclein. Deposited aggregates of a protein called alpha-synuclein (α-syn) can damage and kill nerve cells, ...
Sep 20, 2023
0
29
In a study by researchers at Lund University the marker DOPA decarboxylase (DCC) was found to be elevated in individuals with Parkinson's disease as well as in people with other diseases that result in dopamine deficiency ...
Sep 19, 2023
0
18
Researchers are gaining new insights into neurological diseases by studying circular RNAs (circRNAs) in brain cells. A new study by investigators from the Brigham and Women's Hospital identified over 11,000 distinct RNA circles ...
Sep 18, 2023
0
29
Patients with Parkinson's disease already face poorer mental and physical health, but now a new study shows they also suffer from decreased levels of hope and self-esteem due to the stigma associated with their disease.
Sep 19, 2023
0
6
An augmented-reality headset is an effective digital tool for improving posture and gait in people with Parkinson's disease, according to a recent Cleveland Clinic trial. Findings were published in Neurorehabilitation and ...
Sep 18, 2023
0
4
